BE898057A - Traitement de la calvitie androide. - Google Patents

Traitement de la calvitie androide.

Info

Publication number
BE898057A
BE898057A BE0/211754A BE211754A BE898057A BE 898057 A BE898057 A BE 898057A BE 0/211754 A BE0/211754 A BE 0/211754A BE 211754 A BE211754 A BE 211754A BE 898057 A BE898057 A BE 898057A
Authority
BE
Belgium
Prior art keywords
calvitis
android
treatment
lower limit
normal range
Prior art date
Application number
BE0/211754A
Other languages
English (en)
Original Assignee
Mortimer Christopher H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mortimer Christopher H filed Critical Mortimer Christopher H
Publication of BE898057A publication Critical patent/BE898057A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un procédé pour réduire la perte des cheveux chez l'homme, caractérisé en ce que l'on administre à un homme, une composition pharmaceutique comprenant un ingrédient actif qui, par son administration, provoque un abaissement des taux en dihydrotestostérone du plasma jusqu'à une valeur sensiblement en-dessous de la limite inférieure de la plage normale, tout en n'abaissant pas le taux en testostérone du plasma en-dessous de la limite inférieure de la plage normale dans une mesure telle qu'elle provoquerait un disfonctionnement sexuel.
BE0/211754A 1982-10-21 1983-10-21 Traitement de la calvitie androide. BE898057A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43579882A 1982-10-21 1982-10-21

Publications (1)

Publication Number Publication Date
BE898057A true BE898057A (fr) 1984-02-15

Family

ID=23729847

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/211754A BE898057A (fr) 1982-10-21 1983-10-21 Traitement de la calvitie androide.

Country Status (3)

Country Link
BE (1) BE898057A (fr)
DE (1) DE3338339A1 (fr)
ZA (1) ZA837859B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046279A3 (fr) * 1998-03-11 2001-02-22 Endorech Inc INHIBITEURS DE LA 17β-HYDROXYSTEROIDE DESHYDROGENASE DU TYPE 5 ET DU TYPE 3 ET METHODES D'UTILISATION ASSOCIEES

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) * 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
EP0240630A3 (fr) * 1986-04-10 1989-01-25 University Of Miami Traitement de l'hyperandrogénie de la peau utilisant des compositions contenant du pregnénolone
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
DE4100975A1 (de) * 1991-01-15 1992-07-16 Weuffen Wolfgang Kosmetische oder pharmazeutische zubereitungen zur verbesserung der haarqualitaet und foerderung des haarwachstums
DE4214953C2 (de) * 1992-05-06 1995-05-18 Arrowdean Ltd Arzneimittel zur Erhöhung des Testosteronspiegels

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046279A3 (fr) * 1998-03-11 2001-02-22 Endorech Inc INHIBITEURS DE LA 17β-HYDROXYSTEROIDE DESHYDROGENASE DU TYPE 5 ET DU TYPE 3 ET METHODES D'UTILISATION ASSOCIEES
US6541463B1 (en) 1998-03-11 2003-04-01 Endorecherche, Inc. Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use

Also Published As

Publication number Publication date
ZA837859B (en) 1984-11-28
DE3338339A1 (de) 1984-04-26

Similar Documents

Publication Publication Date Title
ATE220896T1 (de) Hydrogelformulierung mit gesteuerter freisetzung
TNSN95061A1 (fr) Derives d'oxalylamino-benzofuranne et benzothienyle
AR055050A1 (es) Composicion farmaceutica que comprende n-etil-9a, 11a, 15s- trihidoxi-17-fenil-18,19,20-trinor-prosta -5z, 13e- dien-1-amida (bimatoprost) y cloruro de benzalconio, y uso de estos compuestos par la preparacion de la misma
WO1998005323A3 (fr) Procede de regulation du systeme reproducteur femelle au moyen d'inhibiteurs de l'angiogenese
RU93058524A (ru) Системы с регулируемым высвобождением и низкими дозами андрогенов, способ их получения и способ лечения с помощью этих систем
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
TNSN99132A1 (fr) Une composition pour la prevention et/ou le traitement de l'osteoporose ou des alterations dues au syndrome de menopause
HK127494A (en) Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
ES2095566T3 (es) Suspension farmaceutica acuosa para agentes activos farmaceuticos.
UY25067A1 (es) Acetato de sertralina, composiciones farmacéuticas que lo contienen y procedimientos de preparación.
BR9713186A (pt) Inibidores de metaloprotease 1,3-diheterocìclicos
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
MXPA02000437A (es) Composicion para el tratamiento de trastornos de secrecion externa.
BE898057A (fr) Traitement de la calvitie androide.
BE900564A (fr) Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
ES2141736T3 (es) Gel, especialmente para uso terapeutico ocular.
FR2397682A1 (fr) Procede et dispositif pour la construction d'une image par tomographie
DK0719276T3 (da) Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
FR2674437B1 (fr) Composition pharmaceutique, utile notamment dans le traitement d'affections gastro-óoesophagiennes.
WO2002031498A3 (fr) Protection de compositions therapeutiques contre l'inactivation induite par un hote
JPS5657102A (en) Automatic control system of farming machine
IT1173679B (it) Mezzi per montare un supporto di mozzo du un veicolo
ES8404182A1 (es) Un metodo de prepara el enantiomero (+) s de secoverin
DK0659079T3 (da) Transdermalt terapeutisk system med pentylentetrazol som aktivt stof.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MORTIMER CHRISTOPHER H.

Effective date: 19891031